Fusion proteins comprising gp39 and CD8
US5945513A · kind A · utility
8Cited by
5References
2Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 30, 1996 |
| Grant date | Aug 31, 1999 |
| Priority date | — |
| Expiry date | Jul 30, 2016 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/73
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to fusion proteins having gp39 protein sequences, which fusion proteins bind to the B cell antigen, CD40. More specifically, the invention relates to fusion proteins having gp39 protein sequences attached to a polypeptide having an amino terminal secretory signal sequence to allow export of the fusion protein out of the recombinant host cell in which it is produced. The fusion proteins of this invention may be useful for promoting B cell proliferation.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.